CAS No. 1380087-89-7
Batch:
Purity:99.04
Chemical Structure
Check the
Pelabresib (CPI-0610)
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
| IUPAC Name | 2-[(4S)-6-(4-chlorophenyl)-1-methyl-4H-[1,2]oxazolo[5,4-d][2]benzazepin-4-yl]acetamide | |
|---|---|---|
| CAS Number | 1380087-89-7 | |
| Molecular Formula |
C20H16ClN3O2 |
|
| Molecular Weight (MW) | 365.81 | |
| SMILES | CC1=NOC2=C1C3=CC=CC=C3C(=NC2CC(=O)N)C4=CC=C(C=C4)Cl | |
| InChIKey | GCWIQUVXWZWCLE-INIZCTEOSA-N |
Pelabresib (CPI-0610) is a potent and selective benzoisoxazoloazepine inhibitor of BET bromodomains, including BRD4. By selectively binding to BET bromodomains, pelabresib disrupts the recruitment of bromodomain proteins to chromatin, thereby suppressing downstream gene expression, including MYC and NSD3 target genes. This inhibition disrupts transcriptional programs involved in oncogenesis and cellular proliferation, leading to suppressed tumor cell growth and induced apoptosis in hematological tumor models. [1]
|
Concentration
Volume
Mass
|
|---|
Batch:
All in vitro solubility values are batch-tested experimental data (non-literature values).
| Solvent | Solubility & Note |
|---|---|
| DMSO |
73 mg/mL
(199.55 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Ethanol | 73 mg/mL |
| Water | Insoluble |
| DMSO |
73 mg/mL
(199.55 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Ethanol | 15 mg/mL |
| Water | Insoluble |
| DMSO |
73 mg/mL
(199.55 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Ethanol | 9 mg/mL |
| Water | Insoluble |
Q: Why does a DMSO stock precipitate in media/saline?
A: It is caused by unheated aqueous media (supersaturation), local solvent shock, or incorrect mixing sequence.
How to fix it?
- Preheat media/saline to 37°C.
- Mix rapidly (pipette/vortex) upon addition.
- For complex mixes, always add the aqueous phase last.
- Re-dissolve minor precipitates with a 37°C water bath and sonication (≤30 min).
- Pelabresib (CPI-0610) Mechanism of Action: BET Inhibition in Hematopoietic Stem Cell Research
- Pelabresib (CPI-0610) Clinical Trials
- Pelabresib (CPI-0610) Working Concentration | Cell Culture | Treatment
- Pelabresib (CPI-0610) Solubility in DMSO
- Pelabresib (CPI-0610) Stock Solution
- Pelabresib (CPI-0610) Storage
- Pelabresib (CPI-0610) Stability
- Pelabresib (CPI-0610) Combination Database
- Pelabresib (CPI-0610) Molecular Weight
- Pelabresib (CPI-0610) SMILES
- Pelabresib (CPI-0610) Chemical Structure (2D and 3D)
- Pelabresib (CPI-0610) MedChemExpress (HY-12863)? Try a better option.
- Pelabresib (CPI-0610) SDS|MSDS
Note: Technical data last updated: Sep 1, 2026.